President Trump decried the “slow and burdensome” approval process for new drugs at the Food and Drug Administration.

But approvals have sharply accelerated over the last several years. For 2016, the median time was about 10 months for regular approvals and eight months for priority ones, according to the agency. That compared to almost 27 months and 20 months, respectively, in 1993.